| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alemtuzumab in T-cell large granular lymphocyte leukaemia
|
Kadia, Tapan M
|
|
2016
|
3 |
1 |
p. e4-e5
nvt p.
|
artikel
|
| 2 |
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study
|
Dumitriu, Bogdan
|
|
2016
|
3 |
1 |
p. e22-e29
nvt p.
|
artikel
|
| 3 |
A resolution for health
|
The Lancet Haematology,
|
|
2016
|
3 |
1 |
p. e1-
1 p.
|
artikel
|
| 4 |
From clinical trials to real-world clinical practice: observations on the direct oral anticoagulants
|
Lip, Gregory Y H
|
|
2016
|
3 |
1 |
p. e2-e3
nvt p.
|
artikel
|
| 5 |
Heart failure and risk of venous thromboembolism: a systematic review and meta-analysis
|
Tang, Liang
|
|
2016
|
3 |
1 |
p. e30-e44
nvt p.
|
artikel
|
| 6 |
Mesenchymal stromal cells for steroid-refractory acute GVHD
|
Parody, Rocío
|
|
2016
|
3 |
1 |
p. e8-e9
nvt p.
|
artikel
|
| 7 |
Risk of venous thromboembolism in patients with heart failure
|
Larsen, Torben Bjerregaard
|
|
2016
|
3 |
1 |
p. e6-e7
nvt p.
|
artikel
|
| 8 |
Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study
|
Ageno, Walter
|
|
2016
|
3 |
1 |
p. e12-e21
nvt p.
|
artikel
|
| 9 |
Survival after mesenchymal stromal cell therapy in steroid-refractory acute graft-versus-host disease: systematic review and meta-analysis
|
Hashmi, Shahrukh
|
|
2016
|
3 |
1 |
p. e45-e52
nvt p.
|
artikel
|
| 10 |
57th American Society of Hematology Annual Meeting
|
Smith, Lan-Lan
|
|
2016
|
3 |
1 |
p. e10-e11
nvt p.
|
artikel
|
Tijdschrift beschrijving